VirtualScopics to Present at the 13th Annual BIO CEO & Investor Conference
Share:
ROCHESTER, N.Y., Feb. 2, 2011 - VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, announced today that Mr. Jeff Markin, the company's president and chief executive officer, will be presenting a corporate overview at the upcoming 13th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City. Mr. Markin's presentation will be on Monday, February 14, 2011 at 10:00 AM EST.
A live webcast of the presentation will be available for 30 days in the Investor Relations section of the company's website, www.virtualscopics.com.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.
SOURCE VirtualScopics, Inc.
CONTACT:
Molly Henderson,
Chief Business and Financial Officer,
Sr. Vice President,
+1-585-249-6231
Web Site: www.virtualscopics.com
